![Herantis Pharma Oyj logo](/logos/HRTIS.HE.webp)
Herantis Pharma Oyj
HEL:HRTIS.HE
Overview | Financials
Company Name | Herantis Pharma Oyj |
Symbol | HRTIS.HE |
Currency | EUR |
Price | 1.69 |
Market Cap | 28,631,304 |
Dividend Yield | 0% |
52-week-range | 1.3 - 3.04 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Antti Vuolanto D.Sc. (Tech) |
Website | https://www.herantis.com |
An error occurred while fetching data.
About Herantis Pharma Oyj
Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD